BENG0003 Chap.10 Therapeutic Products and Tissue Engineering
Therapeutic Products and Tissue Engineering
Therapeutic Products and Tissue Engineering covers the Week 15 applications lectures, where the engineering from earlier weeks is applied to real medicines.
It opens with antibiotics: natural, semi-synthetic and fully synthetic agents, the rise of penicillin titres from about 1 g/L in the 1940s to around 50 g/L in modern fed-batch tanks, and why a secreted secondary metabolite is recovered from the liquid after the mycelium is removed.
Monoclonal antibodies follow, from the 1975 hybridoma method to the titres quoted for mouse ascites, free culture and encapsulated cells, and the move to recombinant hosts. The vaccine section names four vaccine types with examples, walks through flu production in embryonated eggs, contrasts it with cell-based routes in MDCK and Vero cells, and sets out the Salk and Sabin polio vaccines accurately.
The final part turns to regenerative medicine: autologous, allogeneic and xenogeneic cell therapies and the scale-out against scale-up choice they force, embryonic, adult and induced pluripotent stem cells compared on potency, safety and ethics, and tissue engineering as defined by Langer and Vacanti in 1993. Past papers and the mock have set this material as short comparisons worth 4 to 13 marks.
What this chapter covers
- 01
Natural, semi-synthetic and synthetic antibiotics with examples
- 02
Penicillin fermentation in fed-batch mode and recovery of a secreted product
- 03
Monoclonal against polyclonal antibodies and the hybridoma technique
- 04
Four vaccine types and an example of each
- 05
Flu vaccine production in embryonated eggs and in cell lines
- 06
Autologous, allogeneic and xenogeneic cell therapy routes
- 07
Embryonic, adult and induced pluripotent stem cells compared
- 08
Tissue engineering, regenerative medicine, repair and regeneration
Worked example · free
Plan egg-based flu vaccine output for a seasonal order
- 1Eggs: one dose needs 1 to 2 eggs, so 3,000,000 doses need between 3,000,000 and 6,000,000 eggs.
- 1Antigen: 3,000,000 doses multiplied by 15 µg per dose gives 45,000,000 µg, which is 45 g of viral antigen in total.
- 1Shortest time: 9 days of egg incubation plus 48 h of virus growth after inoculation, which is 11 days.
- 1Longest time: 11 days of egg incubation plus 96 h of virus growth, which is 15 days.
- 1The egg incubation stage, at 9 to 11 days, is the longest step, so it limits how quickly a new batch can be started.
- 1Scale check: 6,000,000 eggs is 6% of the more than 100 million eggs the lecture says are used for influenza in the USA each year.
Key terms
- Secondary metabolite
- A compound such as penicillin that cells make mainly after rapid growth stops, during the stationary phase.
- Hybridoma
- A fused cell combining an antibody-producing B cell with an immortal myeloma cell, so one antibody can be made indefinitely.
- Toxoid vaccine
- Vaccine built from a bacterial toxin that has been inactivated so it triggers immunity without causing disease.
- Allogeneic cell therapy
- Treatment using cells from a different human donor, made in bulk batches that can be stocked off the shelf.
- Induced pluripotent stem cell
- Adult somatic cell reprogrammed with transcription factors so that it regains the ability to form any body cell type.
Therapeutic Products and Tissue Engineering FAQ
Is penicillin a broad-spectrum antibiotic?
Natural penicillin G mainly acts on Gram-positive bacteria, so it is better described as relatively narrow in spectrum, even though one lecture slide labels it broad. Wider activity came from semi-synthetic derivatives such as ampicillin and amoxicillin, made by chemically or enzymatically modifying the penicillin G molecule produced by Penicillium chrysogenum.
Why is penicillin made in fed-batch rather than batch culture?
Penicillin forms mostly once the fungus stops growing quickly. Adding sugar gradually keeps the culture in a productive stationary state for longer instead of exhausting nutrients early, and this is part of why industrial titres climbed to roughly 50 g/L compared with about 1 g/L in the 1940s work of Florey and Chain.
What is the difference between the Salk and Sabin polio vaccines?
Salk's injected vaccine, released in 1955, uses virus killed with formaldehyde and gives IgG protection estimated at 60 to 90%. Sabin's 1957 oral vaccine uses live weakened virus, builds mucosal immunity in the gut, but can occasionally revert and cause polio, at about 1 in 750,000 doses. Salk grew his virus in primary monkey kidney cells, not the later Vero line.
How do I compare autologous and allogeneic cell therapy in an exam answer?
Give each route a definition, its immune consequence and its manufacturing model. Own-patient cells avoid rejection but vary in quality and are scaled out as many small parallel lots. Donor cells allow bulk stock for many recipients through scale-up, but bring rejection risk and the need to hold critical quality attributes. The model answer gives two marks to each side.
Which stem cells carry a teratoma risk?
Pluripotent cells carry the main tumour concern. Embryonic stem cells can form teratomas, and induced pluripotent cells add worries about viral reprogramming vectors and genomic instability, so both need further safety research. Adult stem cells such as mesenchymal cells are multipotent, senesce after limited passages and are regarded as posing few safety concerns, which is one reason they appear in early clinical products.
Exam move
Treat this chapter as four comparison tables you can rebuild from memory. For antibiotics, list the three kinds with one example each, then add the 1 g/L to 50 g/L history and the fed-batch reason. For antibodies, practise the hybridoma sequence as numbered steps and work one volume calculation from a titre, keeping micrograms and millilitres visible.
For vaccines, learn four types with examples and redraw the egg route with its days, hours and temperatures, because the model answer marks it in stages. For cell therapy and stem cells, write autologous and allogeneic side by side with definition, immune effect and scale-out or scale-up, then fill a three-column table for embryonic, adult and induced cells.
Finish by timing yourself on a 10-mark comparison and checking each row has a paired contrast rather than a lone list.